top of page
Translate breakthrough discoveries...
To develop nucleic acid therapeutics, through a blend of proprietary chemistry and novel biology, to solve unmet medical needs and improve lives.
Cargene is a preclinical-stage biopharmaceutical company developing oligonucleotide therapeutics across a broad range of diseases and targeting a variety of organs and tissues.
With sites in Singapore, China and USA, Cargene leverages our chemistry and biological insights to deliver clinically meaningful treatments.
Meet Our Team
The Cargene management and scientific team comprises experienced biotech and life science professionals with diverse expertise ranging from research and development, business development, clinical affairs, manufacturing, and commercialization.
bottom of page